The UAE Launches Sputnik V Vaccine Study

The Russian Direct Investment Fund announced on October 12, 2020, the approval by the Ministry of Health and Prevention of the United Arab Emirates (UAE) to conduct Phase III clinical trials of the Sputnik V vaccine. Similar Phase III clinical trials have been launched in Russia and the Republic of Belarus.

Previously, results from Phase I-II clinical trials of the Sputnik V vaccine were published by The Lancet on September 18, 2020, which showed that sustained humoral and cellular immune responses were achieved in 100% of the volunteers without any serious adverse events.